$102.82 -0.12 (%) Gilead Sciences Inc - NASDAQ

Apr. 28, 2015 | 11:45 AM

Partner Headlines

  1. Looking Ahead of Wall Street: Apple, GoPro, Gilead Sciences

    GuruFocus | Apr. 27, 2015 | 17:40PM EST
  2. 4 Top-Rated Drugmakers Reporting Earnings This Week

    IBD | Apr. 26, 2015 | 08:02AM EST
  3. AbbVie Focusing On Diversification Routes To Put Higher Sales Numbers On The Board

    GuruFocus | Apr. 24, 2015 | 14:05PM EST
  4. Biogen Earnings Preview: What To Look For

    IBD | Apr. 23, 2015 | 19:45PM EST
  5. AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed

    IBD | Apr. 23, 2015 | 17:44PM EST
  6. AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed

    IBD | Apr. 23, 2015 | 11:46AM EST
  7. Forget Google: 5 Top Stocks With Earnings Thursday

    IBD | Apr. 22, 2015 | 19:31PM EST
  8. Benzinga's M&A Chatter for Tuesday April 21, 2015

    Benzinga | Apr. 21, 2015 | 19:37PM EST
  9. Gilead Sciences

    IBD | Apr. 21, 2015 | 18:48PM EST
  10. Weekly CFO Sells Highlight: Gilead Sciences Inc, CarMax Inc, Anthem Inc.

    GuruFocus | Apr. 20, 2015 | 11:41AM EST
  11. How To Invest In ETFs: Tips To Trade Top Market Trends

    IBD | Apr. 17, 2015 | 20:04PM EST
  12. Drug Costs Soar 13% In 2014

    IBD | Apr. 14, 2015 | 19:00PM EST
  13. J&J Earnings Beat Estimates; Guidance Mixed

    IBD | Apr. 14, 2015 | 17:48PM EST
  14. J&J Earnings Beat Estimates; Guidance Mixed

    IBD | Apr. 14, 2015 | 11:12AM EST
  15. AbbVie Upgraded On $7.8 Billion Imbruvica Potential

    IBD | Apr. 13, 2015 | 11:19AM EST
  16. Pioneer Fundamental Growth Fund: Why Is It Revving Up?

    IBD | Mar. 3, 2015 | 17:22PM EST
  17. Making Money With Charles Payne: 02/27/15

    FoxBusiness | Feb. 27, 2015 | 18:00PM EST
  18. ImmunoVaccine Up 24% On Deal With Gilead Sciences

    Benzinga | Feb. 27, 2015 | 12:50PM EST
  19. UPDATE: Gilead Press Release Regarding Phase 3 Harvoni Study

    Benzinga | Feb. 26, 2015 | 15:15PM EST
  20. UPDATE: Gilead Reports Preclinical Data

    Benzinga | Feb. 25, 2015 | 15:29PM EST
  21. New Potential HIV Vaccine Drug 'Absolutely 100% Effective' In Monkeys

    Benzinga | Feb. 20, 2015 | 07:22AM EST
  22. What Steven Cohen Is Doing With His Personal Wealth

    Benzinga | Feb. 18, 2015 | 15:42PM EST
  23. Tiger Management's Julian Robertson Buys Apple, Netflix, Illumina, Sells Alibaba, EBay, MasTec

    GuruFocus | Feb. 17, 2015 | 18:23PM EST
  24. Leon Cooperman's Omega Advisors Bought Gilead, Boosted Groupon & Liquidated Alibaba Last Quarter

    Benzinga | Feb. 17, 2015 | 15:55PM EST
  25. Biotech Performance 'Particularly Impressive,' Says JP Morgan

    Benzinga | Feb. 17, 2015 | 13:30PM EST
  26. Top 5 Biotech Stocks That The Smart Money Doesn't Like

    Benzinga | Feb. 17, 2015 | 12:17PM EST
  27. Gilead Sciences, Atlas Energy And Others Insiders Have Been Buying

    Benzinga | Feb. 14, 2015 | 19:46PM EST
  28. Netflix, Amazon Lead Q4 With Biggest Earnings Beat

    IBD | Feb. 13, 2015 | 16:41PM EST
  29. 8 Strong Recommendations for 2015

    GuruFocus | Feb. 13, 2015 | 15:36PM EST
  30. JMP Securities Covers Mostly Good News From Pharma Pending More Visibility

    Benzinga | Feb. 11, 2015 | 07:54AM EST
  31. Achillion Pharmaceuticals Stock Soars Following Successful Mid-Stage Hep C Drug Combo Trial

    GuruFocus | Feb. 10, 2015 | 12:36PM EST
  32. Jefferies Analyst Says AbbVie Hepatitis C Price-War Fears Overblown

    Benzinga | Feb. 9, 2015 | 11:46AM EST
  33. Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest Profit Margin

    Benzinga | Feb. 9, 2015 | 04:35AM EST
  34. Big Apple Fuels Earnings While Big Energy A Drag

    IBD | Feb. 6, 2015 | 19:04PM EST
  35. Gilead Sciences Offering Fresh Wave Of Competition To AbbVie's Viekira Pak

    GuruFocus | Feb. 6, 2015 | 10:59AM EST
  36. Credit Suisse Downgrades Gilead Sciences, Sees Declining HCV Revenues

    Benzinga | Feb. 6, 2015 | 09:34AM EST
  37. Benzinga's Top Downgrades

    Benzinga | Feb. 6, 2015 | 09:06AM EST
  38. Credit Suisse Downgrades Gilead Sciences To Neutral

    Benzinga | Feb. 6, 2015 | 07:53AM EST
  39. Gilead Sciences Falls 10% After More Than Doubling Drug Discounts For 2015

    GuruFocus | Feb. 5, 2015 | 11:35AM EST
  40. Merck hep C drug faces delays

    IBD | Feb. 4, 2015 | 19:29PM EST
  41. Gilead

    IBD | Feb. 4, 2015 | 19:28PM EST
  42. Stocks Fade In Late Trade; Hain Celestial Jumps

    IBD | Feb. 4, 2015 | 14:50PM EST
  43. HCV Stocks Struggle As Gilead, Merck Face Headwinds

    IBD | Feb. 4, 2015 | 12:12PM EST
  44. Gilead Sciences Getting Crushed On Mixed Results

    Benzinga | Feb. 4, 2015 | 11:59AM EST
  45. AbbVie's Q4 Reflects Its Tremendous Growth Potential Going Forward

    GuruFocus | Feb. 4, 2015 | 11:58AM EST
  46. Stocks Turn Mixed; Airlines Cruise Up

    IBD | Feb. 4, 2015 | 11:52AM EST
  47. Thornburg Value Fund Q4 2014 Commentary

    GuruFocus | Feb. 4, 2015 | 11:24AM EST
  48. Stocks, Volume Get Mixed Start; Sony, Manhattan, Noah Spike

    IBD | Feb. 4, 2015 | 10:43AM EST
  49. Morning Market Losers

    Benzinga | Feb. 4, 2015 | 09:54AM EST
  50. Wednesday Morning Movers: Gilead Sciences, Myriad Genetics Tumble Following Earnings

    Benzinga | Feb. 4, 2015 | 09:39AM EST
Trading Center